[Webinar] Translarna® (ataluren) Development Update - January 2019

(44:18)

Late Breaking News: Ataluren / Translarna -- PPMD 2022 Annual Conference

(25:46)

Translarna for Duchenne Muscular Dystrophy

(2:23)

Portrait of Duchennne - Ataluren a promising treatment for DMD

(4:37)

In the Pipeline: Restoring Dystrophin - PTC Therapeutics (Ataluren)

(11:21)

Translarna (Ataluren) for nonsense mediated Duchenne Muscular Dystrophy

(13:49)

George tells us why he wants Translarna

(16)

PTC Therapeutics (Translarna) [PPMD's 2015 Connect Conference]

(17:9)

Webinar: Ataluren Update with PTC

(54:42)

Trial Update: Translarna - PTC Therapeutics [PPMD's 2017 Connect Conference]

(21:22)

Ataluren - the meta-analysis

(8:42)

Study 019 Clinical Trial Data for Ataluren 1

(2:3)

Community Webinar Series 2021: PTC - Ataluren, Clinical Trials, and Genetic Testing 101

(57:10)

EAC 2021 - 22 - Ataluren STAR trial patient retrospective - Calnan \u0026 Mathew Sorenson

(5:50)

Ataluren Clinical Trial

(11:51)

ACT DMD Update with PTC (February 2014)

(1:3:23)

A World of Smiles Telethon - Tarren Parmar

(3:22)

ESHRE 2013 - Allan TEMPLETON - Honorary member

(5:29)

C. Lagier-Tourenne -Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS

(39:1econd)

Pathogenic Tau Activates Signaling Pathways to Disrupt Fast Axonal Transport

(55:48)